MicroRNA-155 is required for effector cd8+ t cell responses to virus infection and cancer

Jan C. Dudda, Bruno Salaun, Yun Ji, Douglas C. Palmer, Gwennaelle C. Monnot, Estelle Merck, Caroline Boudousquie, Daniel T. Utzschneider, Thelma M. Escobar, Rachel Perret, Stefan A. Muljo, Michael Hebeisen, Nathalie Rufer, Dietmar Zehn, Alena Donda, Nicholas P. Restifo, Werner Held, Luca Gattinoni, Pedro Romero

Research output: Contribution to journalArticlepeer-review

255 Scopus citations

Abstract

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8+ T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8+ T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8+ T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155-/- CD8+ T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8+ T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8+ T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.

Original languageEnglish
Pages (from-to)742-753
Number of pages12
JournalImmunity
Volume38
Issue number4
DOIs
StatePublished - 18 Apr 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'MicroRNA-155 is required for effector cd8+ t cell responses to virus infection and cancer'. Together they form a unique fingerprint.

Cite this